Abstract

MGIC Investment is scheduled to release its fiscal first‑quarter 2026 results on April 29, 2026 Post Market; this preview outlines expected revenue, profitability, and earnings per share alongside sell‑side sentiment and the key operational factors investors should watch.

Market Forecast

Consensus indicators point to a steady top line and solid profitability for the upcoming quarter: revenue is projected at 304.33 million US dollars, implying a year‑over‑year decline of 0.46%, while adjusted EPS is estimated at 0.75, implying 9.20% year‑over‑year growth. No explicit guidance for gross profit margin or net profit margin is available for the current quarter from the collected datasets, though both measures have recently been elevated; absent formal guidance, markets are looking for stability rather than directional change.

The main business is expected to remain anchored by net premiums and credit performance, with management attention on loss development, new insurance written, and premium yield resilience to protect earnings quality through the quarter. Within reported segments, investment income stands out as a supportive earnings contributor; it totaled 61.61 million US dollars last quarter, and momentum is expected to be aided by reinvestment yields, while the company‑wide revenue outlook indicates a mild year‑over‑year contraction of 0.46% for this quarter.

Last Quarter Review

In the prior quarter, MGIC Investment reported revenue of 298.65 million US dollars (down 0.93% year over year), a gross profit margin of 94.64%, GAAP net income attributable to shareholders of 169.00 million US dollars, a net profit margin of 56.69%, and adjusted EPS of 0.75 (up 4.17% year over year). One notable highlight was that net income decreased sequentially by 11.40%, reflecting quarter‑to‑quarter variability even as the year‑over‑year EPS trend remained positive.

By line of business, net premiums contributed 236.02 million US dollars and continued to represent the primary revenue stream, while investment income was 61.61 million US dollars; total revenue in the quarter contracted 0.93% year over year, underscoring a broadly stable, high‑margin earnings base despite modest top‑line pressure.

Current Quarter Outlook

Main Business: Premiums, Delinquencies, and Earnings Quality

The core engine for this quarter remains the premiums‑driven insurance operation, where revenue and earnings will be determined by the interaction of new insurance written, persistency, and credit performance. Investors should monitor premium yield dynamics, which can be influenced by portfolio mix and policy cancellations; flat to slightly lower premium yields can still translate into steady earnings if cures continue to outpace new notices. Credit metrics are the most sensitive swing factor for underwriting income: a benign claims environment supports high margins and earnings stability, whereas a pickup in serious delinquencies, cure‑to‑claim conversions, or claim severity could pressure the loss ratio and net income. With the prior quarter posting an elevated gross profit margin of 94.64% and a net profit margin of 56.69%, the starting point for profitability is robust; absent an adverse shift in loss costs, the company can maintain healthy run‑rate earnings even on a largely stable revenue base.

Operationally, sequential trends deserve attention given the prior quarter’s 11.40% quarter‑over‑quarter decline in net income. While that decline came against a backdrop of high absolute margins, the near‑term task is to show that last quarter’s softness was seasonal or timing‑related rather than a structural deterioration in credit costs or premiums. In this context, management’s commentary around delinquency inflows, cures, and reserve development will be pivotal. If cures remain favorable and incurred losses stay contained, the company should be able to deliver EPS in line with the 0.75 estimate while preserving capital flexibility for buybacks and dividends. Conversely, even a modest uptick in claims severity or a slower cure rate could dent the net profit margin, which would be visible in the bottom line given limited revenue growth.

Another area to watch is persistency and the seasonality of new insurance written. Lower refinancing activity typically lifts persistency, supporting premium volumes and earnings carryover from in‑force policies. However, persistency benefits can be offset by the natural seasoning of policy cohorts and any changes in premium rates or underwriting mix. A steady policy count, combined with high‑quality credit performance, should be sufficient to keep premiums as the main pillar of earnings in the current quarter, with any variance most likely showing up through the claims line rather than premium revenue itself.

Most Promising Contributor: Investment Income and Portfolio Levers

Investment income is positioned to be a constructive stabilizer for earnings this quarter, reflecting the last quarter’s 61.61 million US dollars contribution and the benefit of reinvesting at contemporary yields. Portfolio duration management and the cadence of maturities can incrementally lift the run‑rate yield as older, lower‑coupon holdings roll off. Even if the top line is essentially flat, incremental basis‑point improvements in portfolio yield can bolster pre‑tax earnings consistency and support the 0.75 EPS consensus. Realized gains and losses are inherently variable, but the core recurring yield component should remain a tailwind compared to the prior year’s base.

Given the company’s dividend continuity and capital return track record, investment income may also indirectly support shareholders through the capacity it affords for distributions and buybacks without compromising regulatory capital. The prior‑quarter dividend declaration of 0.15 US dollars per share points to an ongoing capital return cadence; maintenance of strong statutory and holding company liquidity typically underpins this approach. Within accounting results, a stable asset base and manageable credit impairments can prevent volatility in the non‑premium portions of revenue; this allows modest yield changes to flow through to the bottom line without material offset.

Looking ahead through the current quarter, market volatility can affect mark‑to‑market movements and realized outcomes, yet core fixed‑income carry should prove durable if the portfolio maintains a high‑quality composition and duration aligned with liability structure. Investors should look for management’s commentary on new‑money yields achieved in the quarter and the expected run‑rate yield for the portfolio heading into the next period; even small changes can make a measurable difference given the size of the investment account relative to quarterly earnings.

Key Stock Price Swing Factors This Quarter

The headline EPS and revenue numbers will frame the initial reaction, but the stock’s move is likely to hinge on qualitative disclosures and what they imply about forward earnings capacity. First, the claims outlook is paramount. If the company reports stable or improving delinquency and loss development, investors may extrapolate today’s margins into subsequent quarters, supporting valuation resilience. Conversely, any commentary suggesting higher claim frequency, slower cures, or elevated severity could lead the market to trim earnings run‑rate expectations, even if the current quarter meets the 0.75 EPS consensus.

Second, premium yield commentary can sway sentiment. The expected slight year‑over‑year decline in total revenue of 0.46% signals that management is navigating a flattish top‑line environment. If premium yields are holding or declining only modestly while the in‑force book remains steady, this would reinforce confidence that EPS growth can be powered by underwriting discipline and low loss ratios. However, a discussion of competitive pricing pressure or mix effects that lower yields could lead investors to build in a more conservative revenue path for the rest of the year.

Third, capital return pace and balance sheet metrics can shape the narrative beyond the quarter. Markets tend to reward visibility into buyback activity and dividend sustainability when earnings are stable. The prior declaration of a 0.15 US‑dollar quarterly dividend helps anchor steady total shareholder return. Any incremental clarity around share repurchases during the quarter, or an updated capital management framework, can positively influence per‑share earnings trajectory and valuation multiples. Given the muted revenue growth projection, capital returns can be a meaningful lever for per‑share results and a buffer for the stock if operating trends remain stable.

Finally, investors will be attuned to management’s color on the forward EPS trajectory. With the consensus implying 9.20% year‑over‑year growth in EPS to 0.75, the path to sustaining or expanding that run rate will be scrutinized. Commentary affirming that current delinquency trends remain benign and that investment yields continue to edge higher could reinforce the durability of earnings per share even if revenue is nearly flat. Absent such reassurance, the stock could consolidate as investors await the next catalyst in credit performance or capital actions.

Analyst Opinions

The balance of recent published views skews Neutral/Hold, indicating a cautious stance that prioritizes earnings stability over aggressive growth expectations. UBS maintained a Neutral rating with a 28 US‑dollar target during the period, highlighting a view that current valuation appropriately reflects steady earnings and robust capital return without a clear upside catalyst in the near term. Barclays also reiterated a Hold rating with a 28 US‑dollar price target, underscoring a similar assessment that the shares are fairly valued against a backdrop of durable profitability and limited top‑line acceleration.

Taking these views together, the majority viewpoint is neutral rather than explicitly bullish or bearish. Analysts emphasizing neutrality point to dependable margins and manageable credit outcomes as reasons to expect in‑line results, while also noting that the revenue projection of 304.33 million US dollars for the quarter implies a slight 0.46% year‑over‑year contraction in the top line. In this framework, the estimated 0.75 adjusted EPS, up 9.20% year over year, is viewed as achievable if loss costs remain contained and investment income trends remain supportive. The commentary surrounding delinquency flows, cures, and any signs of claim severity changes will be closely parsed; a steady read‑through there would validate the Neutral stance, whereas any suggestion of loss pressure would encourage a more conservative posture.

Neutral‑leaning analysts also focus on capital returns as an important component of total shareholder outcomes when revenue growth is muted. The prior quarter’s regular dividend of 0.15 US dollars per share supports the case for ongoing cash returns, and clarity on buyback activity can influence per‑share earnings momentum through the year. Importantly, the Neutral consensus does not preclude upside if results show favorable credit dynamics and improving investment yields; rather, it reflects a base case that this quarter will align with expectations on revenue and EPS with limited directional surprises. As a result, the majority stance into April 29, 2026 is that MGIC Investment is positioned to deliver in‑line earnings, with the stock reaction likely to be driven by commentary on loss development, premium yields, and capital deployment rather than headline revenue prints alone.